Dec 10, 2018
This episode features Dr Sophie Rees ( University of Warwick,
Coventry, UK ) and Dr Ann Hutchinson ( University of Hull, Hull, UK
)
Cancer patients are at an increased risk of thrombosis. Current
guidance for treatment is injected anticoagulants although there is
some doubt as to the long-term acceptability of injections to
patients. Many cancer patients are unaware of their increased risk
of thrombosis or of the symptoms that should prompt seeking medical
attention. Cancer patients find injected anticoagulants acceptable
in the context of cancer, especially when given support to overcome
initial anxieties. Patients find taking tablets easier, but would
only choose tablets over injections if found to be as safe and
effective as injected anticoagulants. Cancer patients must be
informed of their increased risk of thrombosis and the symptoms for
which they should seek help. Rivaroxaban tablets could be offered
as a choice when there are sufficient robust data to support the
risk–benefit balance.
Full paper available from: https://journals.sagepub.com/doi/10.1177/0269216318815377
If you would like to record a podcast about your published (or accepted) Palliative Medicine paper, please contact Dr Amara Nwosu: anwosu@liverpool.ac.uk